PHREESIA INC (PHR) Stock Overview
USA - NYSE:PHR - US71944F1066 - Common Stock
PHR Key Statistics, Chart & Performance
The current stock price of PHR is 23.27 USD. In the past month the price decreased by -17.28%. In the past year, price increased by 4.87%.
PHR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.77 | 48.56B | ||
| DOCS | DOXIMITY INC-CLASS A | 49.17 | 13.72B | ||
| WAY | WAYSTAR HOLDING CORP | 34.81 | 6.73B | ||
| HTFL | HEARTFLOW INC | N/A | 3.14B | ||
| CERT | CERTARA INC | 26.67 | 2.10B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.59B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 12.94 | 1.57B | ||
| SDGR | SCHRODINGER INC | N/A | 1.52B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 967.11M | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 908.61M | ||
| CTEV | CLARITEV CORP | N/A | 841.45M |
Related stock screener links
About PHR
Company Profile
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Wilmington, Delaware and currently employs 2,082 full-time employees. The company went IPO on 2019-07-18. The firm's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The firm's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Company Info
PHREESIA INC
1521 Concord Pike, Suite 301 Pmb 221
Wilmington DELAWARE 27601 US
CEO: Chaim Indig
Employees: 2082
Phone: 18886547473
PHREESIA INC / PHR FAQ
What is the stock price of PHREESIA INC today?
The current stock price of PHR is 23.27 USD. The price increased by 1.88% in the last trading session.
What is the ticker symbol for PHREESIA INC stock?
The exchange symbol of PHREESIA INC is PHR and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is PHR stock listed?
PHR stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for PHREESIA INC stock?
20 analysts have analysed PHR and the average price target is 34.83 USD. This implies a price increase of 49.66% is expected in the next year compared to the current price of 23.27. Check the PHREESIA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PHREESIA INC worth?
PHREESIA INC (PHR) has a market capitalization of 1.39B USD. This makes PHR a Small Cap stock.
How many employees does PHREESIA INC have?
PHREESIA INC (PHR) currently has 2082 employees.
What are the support and resistance levels for PHREESIA INC (PHR) stock?
PHREESIA INC (PHR) has a support level at 23.26 and a resistance level at 24.74. Check the full technical report for a detailed analysis of PHR support and resistance levels.
Is PHREESIA INC (PHR) expected to grow?
The Revenue of PHREESIA INC (PHR) is expected to grow by 14.04% in the next year. Check the estimates tab for more information on the PHR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PHREESIA INC (PHR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PHR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PHR, evaluating the profitability, health, valuation and growth aspects
- PHREESIA INC (PHR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PHREESIA INC (PHR) Sales and EPS estimates to see what analysts future expectations are.
- PHREESIA INC (PHR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PHREESIA INC (PHR) Insider and Institutional Ownership to learn about the owners and their transactions.
- PHREESIA INC (PHR) Stock Chart to make your own analysis
- PHREESIA INC (PHR) Latest news and press-releases to stay up to date.
Does PHREESIA INC (PHR) stock pay dividends?
PHR does not pay a dividend.
When does PHREESIA INC (PHR) report earnings?
PHREESIA INC (PHR) will report earnings on 2025-12-08, after the market close.
What is the Price/Earnings (PE) ratio of PHREESIA INC (PHR)?
PHREESIA INC (PHR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.42).
What is the Short Interest ratio of PHREESIA INC (PHR) stock?
The outstanding short interest for PHREESIA INC (PHR) is 5.92% of its float. Check the ownership tab for more information on the PHR short interest.
PHR Technical Analysis
PHR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to PHR. The financial health of PHR is average, but there are quite some concerns on its profitability.
PHR Financial Highlights
Over the last trailing twelve months PHR reported a non-GAAP Earnings per Share(EPS) of -0.42. The EPS increased by 62.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.89% | ||
| ROE | -8.07% | ||
| Debt/Equity | 0.02 |
PHR Forecast & Estimates
20 analysts have analysed PHR and the average price target is 34.83 USD. This implies a price increase of 49.66% is expected in the next year compared to the current price of 23.27.
For the next year, analysts expect an EPS growth of 95.04% and a revenue growth 14.04% for PHR